Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Christie Beatson

Concepts (57)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypoglycemic Agents
7
2025
1411
0.880
Why?
Diabetes Mellitus, Type 1
11
2025
3930
0.700
Why?
Overweight
4
2025
613
0.480
Why?
Glucagon-Like Peptides
3
2025
76
0.420
Why?
Blood Glucose
9
2025
2357
0.330
Why?
Obesity
4
2025
3123
0.260
Why?
Blood Glucose Self-Monitoring
4
2018
704
0.200
Why?
Drug Approval
1
2024
93
0.200
Why?
Insulin
4
2024
2524
0.190
Why?
Weight Loss
2
2025
857
0.170
Why?
Diabetic Nephropathies
1
2025
320
0.170
Why?
Postprandial Period
2
2024
114
0.140
Why?
Glucagon-Like Peptide 1
2
2025
150
0.130
Why?
Insulin Infusion Systems
2
2024
488
0.130
Why?
Eczema
1
2018
66
0.130
Why?
Diabetes Mellitus, Type 2
2
2024
2623
0.100
Why?
Skin
1
2018
701
0.100
Why?
Cardiovascular Diseases
1
2025
2218
0.090
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2013
46
0.090
Why?
Pyrazines
1
2013
94
0.090
Why?
Glucagon
1
2013
114
0.090
Why?
Body Mass Index
3
2025
2446
0.090
Why?
Triazoles
1
2013
190
0.080
Why?
Infusions, Subcutaneous
1
2011
23
0.080
Why?
Injections, Subcutaneous
1
2011
170
0.080
Why?
Monitoring, Ambulatory
1
2009
88
0.070
Why?
Retrospective Studies
4
2025
17291
0.060
Why?
Humans
11
2025
145625
0.060
Why?
Adult
8
2025
40821
0.060
Why?
Middle Aged
6
2025
36359
0.050
Why?
Insulin, Short-Acting
1
2024
8
0.050
Why?
Gastric Inhibitory Polypeptide
1
2024
13
0.050
Why?
Glucagon-Like Peptide-2 Receptor
1
2024
16
0.050
Why?
Insulin, Regular, Human
1
2024
47
0.050
Why?
Software
1
2008
673
0.050
Why?
Administration, Inhalation
1
2024
567
0.050
Why?
Treatment Outcome
3
2025
11744
0.040
Why?
Glomerular Filtration Rate
1
2025
743
0.040
Why?
Male
7
2025
73014
0.040
Why?
Female
7
2025
79080
0.040
Why?
Glucose
1
2024
1051
0.030
Why?
Blood Pressure
1
2025
1761
0.030
Why?
Prospective Studies
2
2024
8087
0.030
Why?
Hypoglycemia
2
2009
489
0.020
Why?
Biomarkers
1
2025
4329
0.020
Why?
Sitagliptin Phosphate
1
2013
31
0.020
Why?
Drug Administration Schedule
1
2011
782
0.020
Why?
Double-Blind Method
1
2013
2064
0.020
Why?
Equipment Design
1
2009
519
0.020
Why?
Safety
1
2009
346
0.020
Why?
United States
1
2024
16041
0.010
Why?
Dose-Response Relationship, Drug
1
2008
2018
0.010
Why?
Sensitivity and Specificity
1
2009
1992
0.010
Why?
Reproducibility of Results
1
2009
3396
0.010
Why?
Algorithms
1
2008
1843
0.010
Why?
Adolescent
1
2013
22451
0.010
Why?
Aged
1
2013
26251
0.010
Why?
Beatson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)